[Cardiogenic shock in acute myocardial infarct]

Related Experiment Video

Updated: Oct 29, 2026

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

J Malík1, J Murín, J Kasper

  • 1I. interná klinika FN, Bratislava.

Vnitrni Lekarstvi
|June 1, 1997
PubMed

Insights

Cardiogenic shock complicates myocardial infarction in 18% of patients, with a 77% mortality rate. Risk factors include age, hypertension, and diabetes, necessitating early intervention and treatment for acute myocardial infarction patients.

Area of Science:

  • Cardiology
  • Internal Medicine
  • Clinical Research

Context:

  • Cardiogenic shock (CS) is a severe complication of acute myocardial infarction (AMI).
  • This study analyzes clinical data from 270 AMI patients over three years to identify CS characteristics and risk factors.

Purpose:

  • To assess the incidence, patient characteristics, and mortality associated with cardiogenic shock in myocardial infarction.
  • To identify key risk factors contributing to the development of cardiogenic shock in AMI patients.
  • To emphasize the importance of preventative and therapeutic strategies for managing CS in AMI.

Summary:

  • The study identified cardiogenic shock in 18% (48/270) of myocardial infarction patients, with a high mortality rate of 77%.
  • Incidence of CS increased with age, particularly in older groups (up to 35%).
  • Risk factors included arterial hypertension, diabetes, anterior infarct localization (first infarctions), and a history of previous infarctions (re-infarctions).

Impact:

  • Highlights the critical need for heightened vigilance and proactive management of acute myocardial infarction patients to prevent CS.
  • Suggests that early thrombolytic therapy, ischemia, and arrhythmia prevention are crucial.
  • Recommends considering thrombolysis or percutaneous coronary intervention (PTCA) during CS treatment.

More Related Videos

Real-time Pressure-volume Analysis of Acute Myocardial Infarction in Mice07:28

Real-time Pressure-volume Analysis of Acute Myocardial Infarction in Mice

Published on: July 2, 2018

Related Concept Videos

Introduction Cardiac Emergencies01:30

Introduction Cardiac Emergencies

Cardiac emergencies are critical situations involving the heart that require immediate medical intervention to prevent severe complications or death. These emergencies often arise from underlying heart conditions that impair the heart's ability to function correctly.Types of Cardiac EmergenciesThe most common types of cardiac emergencies include Acute Coronary Syndrome (ACS), myocardial infarction (MI), cardiac arrest, and heart failure.Acute Coronary Syndrome (ACS)Acute Coronary Syndrome (ACS)...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...